Nateglinide
16 NDCs across 7 manufacturers|16 Generic,0 Brand
Nateglinide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 22, 2000, and the first generic was approved Sep 9, 2009. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $8 million on Nateglinide across 150,000 claims for 38,000 beneficiaries.
Nateglinide is available as 16 NDCs from 7 manufacturers (16 generic, 0 brand), with NADAC prices from $0.18 to $0.24 per EA — a 34% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
16G / 0B
Manufacturers
7
competing in market
Price Spread
$0.18 – $0.24
per EA
7d Activity
avg -5.5% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Modavar Pharmaceuticals LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Glinide class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing NATEGLINIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NATEGLINIDE 120 MG TABLET | $0.2411 per EA | — |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 120 MG TABLET | $0.2222 per EA | -5.24% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
NATEGLINIDE 60 MG TABLET | $0.1794 per EA | -5.68% |
Frequently Asked Questions
What is Nateglinide used to treat?
Nateglinide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Nateglinide become available as a generic?
FDA approved the first generic Nateglinide (ANDA) on Sep 9, 2009. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Nateglinide?
In 2024, Medicare Part D spent $8 million on Nateglinide across 150,000 claims for 38,000 beneficiaries.
How many Nateglinide products are on the market?
The Nateglinide drug market contains 16 NDCs from 7 manufacturers — 16 generic and 0 brand products.
What is the price range for Nateglinide?
NADAC reference prices for Nateglinide range from $0.1794 to $0.2411 per EA — a 34% difference between cheapest and most expensive.
Which manufacturers make Nateglinide?
7 manufacturers list Nateglinide in NADAC. Ranked by number of NDCs, the largest are Modavar Pharmaceuticals LLC (4), Dr. Reddy's Laboratories Inc. (2), Rising Pharma Holdings Inc. (2), Zydus Pharmaceuticals (USA) Inc. (2), American Health Packaging (2).
How has the price of Nateglinide changed recently?
Over the past 7 days, 0 Nateglinide NDCs rose and 15 fell, with a market-wide average change of -5.5%.